EnVivo Pharmaceuticals, Inc. Company Profile
EnVivo Pharmaceuticals, Inc. and its subsidiaries (“EnVivo Pharmaceuticals” or “EnVivo”) are dedicated to discovering and developing small molecule therapeutics for disorders of the central nervous system (CNS). EnVivo Pharmaceuticals, Inc. is a biotech company located in Watertown, Mass. The company’s focus is on building an integrated company and it is working to convert its broad pipeline into a range of CNS therapies that leverage novel mechanisms of action by altering the progression of disease and providing improvement in cognitive and overall function. EnVivo’s lead product is an alpha-7 nicotinic acetylcholine receptor agonist that has successfully completed a Phase 2b clinical trial in schizophrenia and is currently in an ongoing Phase 2b clinical trial for the treatment of cognitive impairment in Alzheimer’s disease. EnVivo’s other clinical programs include an epigenetics program based on Histone Deacetylase inhibition (HDACi), a Gamma Secretase Modulator program and several preclinical programs, including a potent and selective PDE10 inhibitor program. For more information about EnVivo, visit www.envivopharma.com.
News Articles
EnVivo Pharmaceuticals locates European office in Leiden
The West Holland Foreign Investment Agency and Leiden Bio Science Park proudly announce that EnVivo...
EnVivo Forges Ahead With Alzheimer’s Drug
The pharmaceutical world went into shock on August 6, when Pfizer, Johnson & Johnson, and Elan Pharmaceuticals pulled the plug on bapineuzumab (“bapi”), a highly anticipated experimental drug...
New Data Presented Build on Positive Phase 2b Findings, Demonstrate Correlation Between Improved Cognition and Plasma Levels of EVP-6124 WATERTOWN, Mass.--(BUSINESS WIRE)--Oct 31, 2012 - EnVivo Pharm...
EVP-6124 Data Presented Today at Alzheimer's Association International Conference (AAIC) 2012; Company Plans to Advance Lead Program into Phase 3 Development WATERTOWN, Mass.--(BUSINESS WIRE)--Jul 18,...
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced the appointment of Alfred Sandrock,...
EnVivo's EVP-6124 meets AD endpoint
EnVivo Pharmaceuticals Inc. (Watertown, Mass.) said once-daily oral EVP-6124 met the co-primary endpoints of improving cognition and clinical function at week 23 vs. placebo in a Phase IIb trial to tr...
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced that the company will present a com...
Latest News From "The Pink Sheet" DAILY - EnVivo Alzheimer's Drug Slowed Cognitive Decline
Degludec Advisory Committee Is Another De Facto Delay For Novo
Drugs and Medications
None
PubMed Articles
RATIONALE: Naturally low prepulse inhibition (PPI) in DBA/2 mice is increased by marketed antipsychotics and compounds acting at novel targets relevant to schizophrenia. Whether other mouse strains wi...
Clinical Trials
None
Companies
EnVivo Pharmaceuticals, Inc. and its subsidiaries (“EnVivo Pharmaceuticals” or “EnVivo”) are dedicated to discovering and developing small molecule therapeutic...
Mission: to discover and develop small-molecule therapeutics for disorders of the central nervous system (CNS), specifically neurodegenerative diseases, such as Alzheimer’s Disease, Parkinson’s Di...
MethylGene is a publicly-traded biopharmaceutical company listed on the Toronto Stock Exchange under the symbol MYG. We focus in the areas of cancer, infectious disease and other diseases such as diab...
More Information about "EnVivo Pharmaceuticals, Inc." on BioPortfolio
We have published hundreds of EnVivo Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of EnVivo Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about EnVivo Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EnVivo Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant EnVivo Pharmaceuticals, Inc. Drugs and Medications on this site too.
